مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

709
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

The evaluation of P16 in chronic myeloid leukemia patients

Pages

  226-234

Abstract

 Background and Objectives: Chronic Myeloid Leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosinkinase. The tumour suppressor gene of P16 plays the key role in the cell cycle control. The inactivation of this gene is associated with tumorgenesis, pathogenesis and progression of leukemia. The aim of this study was to evaluate the expression of P16 gene in patients with Chronic Myeloid Leukemia for the identification of the gene expression changes so that the role of the gene in diagnosis and treatment of the disease could be determined. Materials and Methods: In this descriptive study, the expression of P16 gene in 40 CML patients in Chronic phase and 8 healthy subjects as the control all in Payvand Medical Laboratory was examined by Real Time PCR technique. Results were analyzed using the Relative Expression Software Tool (REST2009). Results: P16 gene expression was significantly down-regulated in 32 patients (p ≤ 0. 05), and upregulated in 8 patients (p ≤ 0. 05) compared to the control group. Conclusions: In conclusion, downregulation or upregulation of P16 may be of importance in the biology of CML. Other studies are also required to elucidate the exact function of this tumor suppressor in cancer.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Barazandeh Rokh, M., NASOOHI, N., MOLAEI, M., & FALLAH, P.. (2018). The evaluation of P16 in chronic myeloid leukemia patients. THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON), 15(3 ), 226-234. SID. https://sid.ir/paper/78781/en

    Vancouver: Copy

    Barazandeh Rokh M., NASOOHI N., MOLAEI M., FALLAH P.. The evaluation of P16 in chronic myeloid leukemia patients. THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON)[Internet]. 2018;15(3 ):226-234. Available from: https://sid.ir/paper/78781/en

    IEEE: Copy

    M. Barazandeh Rokh, N. NASOOHI, M. MOLAEI, and P. FALLAH, “The evaluation of P16 in chronic myeloid leukemia patients,” THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON), vol. 15, no. 3 , pp. 226–234, 2018, [Online]. Available: https://sid.ir/paper/78781/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button